Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.
The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...